Program Overview:
2015 has been a wild ride, but how does it compare to 2013 and 2014? What does it take to go IPO and when are acquirers engaging in M&A? This presentation will explore the current state of the BioPharma venture world and include the following topics:

• What does it take to go IPO and when are acquirers engaging in M&A?
• Explore current equity financings vs. the last three years
• Analysis of which venture firms are most active
• The crossover phenomenon and what does it mean for your company?
– Which crossovers are investing and at which stage
– Step-up in private equity rounds
– IPO pre-money valuation and IPO success
• Exits: the trend to early stage M&A in Biopharma, and explore time to exit, up front and all-in values, and multiples on capital invested by indication.
• IPOs:
– Types of IPOs completed since 2013 and changes in 2015 to date
– Average dollars raised and pre money by indication.

At the end of this talk you should be informed as to who is investing in BioPharma and comps for M&A and IPO in your indication.

Agenda:
8:00am | Registration and Networking
8:30am | Presentation and Q&A
9:30am | Networking
10:00am | Close